VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3329
ETF rank
โ‚ฌ15.33 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
23,23ย โ‚ฌ
Share price
-0.68%
Change (1 day)
27.15%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of September 2026: 0.35%